Carl Zeiss Meditec AG(CZMWF)
USD --+0.00%
Reward55Moderate
Risk34Moderate
📊75%Data
2.2% dividend yield
CZMWF
+0.0 · +0.00%
USD · PINK
Carl Zeiss Meditec AG | Healthcare
Dividend King
Market Cap:2.63Bn
ℹ️
Reward Rating
55
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
34
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on CZMWF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: €130.00.

What is Carl Zeiss Meditec AG?

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia.

CZMWF · Verdict

Solid reward · moderate risk

CZMWF stands out on balance sheet and cash flow, but watch the volatility signal.

Based on 88% data coverage

CZMWF · Verdict

What’s working & what to watch

Strengths 2

  • Balance sheet83/100

    Interest covered 9.7×

  • Cash flow72/100

    9% free-cash-flow margin

Watchouts 1

  • Volatility35/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Carl Zeiss Meditec AG?

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.63B, and a P/E ratio of 15.8x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (55)

The scoring profile indicates moderate reward potential, with valuation and growth as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap2.63B
P/E Ratio15.8
Dividend Yield2.16%
52 Week High70.88
52 Week Low30.02
Last AnnualSeptember
IPO DateN/A
IncorporatedUSA
Shares Outstanding88M
No. of Employees5,784
IndustryMedical Instruments & Supplies
ExchangePINK
Beta1.435
CurrencyUSD · Reports in EUR